Nurse Practitioner, Adult Health · Hartford, CT
NPI
1104175520
Since 2012
Specialty
Nurse Practitioner, Adult Health
Code 363LA2200X
Group practices
3
Medicare group memberships
Hospitals
1
Hospital affiliations
80 Seymour Street, Hartford Hospital Infectious Disease
Hartford, CT, 06102
Phone (860) 972-2878
Groups this clinician bills Medicare through
Medicare paid, 2024
$2,955
81 services
Medicare patients, 2024
25
Average age 62
Drug cost, 2024
$4.4M
4,982 prescriptions
Company payments, 2025
$843
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ana L Caceres was code 99213 (office e&m - established), 51 times for 22 patients. In total Ana L Caceres billed 81 services in 8 codes, and Medicare paid $2,955.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-12-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Facility | 51 | 22 | $36.13 | $1,843 |
By year: 2022 $4,726 for 109 services; 2023 $3,290 for 80 services; 2024 $2,955 for 81 services.
Medicare prescription drug claims, 2024
In 2024, the drug Ana L Caceres prescribed most often to Medicare patients was Biktarvy (Bictegrav/Emtricit/Tenofov Ala), with 387 prescriptions and refills. In total Ana L Caceres wrote 4,982 Medicare prescriptions that cost $4.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 387 | 397 | 44 | $1.6M |
| Juluca Dolutegravir/Rilpivirine | 254 | 254 | 28 | $934K |
| Amlodipine Besylate Generic | 227 | 297 | 33 | $639 |
| Atorvastatin Calcium Generic | 193 | 304 | 36 | $748 |
| Gabapentin Generic | 149 | 202 | 26 | $1,803 |
| Pantoprazole Sodium Generic | 140 | 168 | 17 | $510 |
| Valacyclovir Valacyclovir Hcl | 130 | 180 | 21 | $4,946 |
| Lisinopril Generic | 122 | 206 | 23 | $346 |
| Dovato Dolutegravir Sodium/Lamivudine | 106 | 106 | 11 | $303K |
| Hydrochlorothiazide Generic | 103 | 145 | 15 | $331 |
| Metoprolol Succinate Generic | 96 | 116 | 11 | $407 |
| Pravastatin Sodium Generic | 94 | 148 | 17 | $548 |
| Metformin Hcl Generic | 78 | 94 | 12 | $236 |
| Rosuvastatin Calcium Generic | 77 | 115 | 14 | $694 |
| Tivicay Dolutegravir Sodium | 77 | 77 | 13 | $170K |
Brand drugs: 1,590 claims; generic drugs: 3,355 claims; opioid claims: 19.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ana L Caceres $843 ($843 in general payments such as food, travel and fees) from 2 companies. The largest payer was Gilead Sciences, Inc. with $745.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.